CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 45,510 shares at an average $37.12 ($1,689,493)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift President and CEO gave 160,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 7,000,000 shares at $34.66 ($242,620,000)
- 4 Open-market sale Director sold 3,500,000 shares at $36.40 ($127,400,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Legal Officer sold 65,000 shares at $38.70 ($2,515,500)
- 4 Open-market sale Chief Financial Officer sold 77,000 shares at $38.68 ($2,978,360)
- 4 Open-market sale Chief Medical Officer sold 82,642 shares at $38.70 ($3,198,245)
- 4 Open-market sale Chief Scientific Officer sold 90,000 shares at $38.74 ($3,486,600)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 139,998 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 367,497 shares (to pay taxes)
Page 1 of 13 · 248 filings